Neuropace Inc.

Last updated September 27, 2026

Organization details

Legal name
Neuropace Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
NPCE
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001528287

Board of directors

Chief executives

Joel Becker · Chief Executive Officer
Since July 2023
Michael Favet · Chief Executive Officer
Until July 2023 · Former

Board connections

4 of this board's directors also sit on 6 other boards.

Network of Neuropace Inc.'s board connections Align Technology Inc. Align Technology Inc. Amanat Acquisition Corp Amanat Acquisition Cor... Envista Holdings Corporation Envista Holdings Corpo... Hyperfine Inc. Hyperfine Inc. QuidelOrtho Corporation QuidelOrtho Corporatio... Tenon Medical Inc. Tenon Medical Inc. Frank M. Fischer Frank M. Fischer Joseph Lacob Joseph Lacob R. Scott Huennekens R. Scott Huennekens Rakhi Kumar Rakhi Kumar Neuropace Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$399,250
1 sale by 1 insider
Date Insider Transaction Shares Price Value
Jun 24, 2026 Morrell Martha Officer (CHIEF MEDICAL OFFICER) Shares withheld for tax −335 $16.22 $5,434
Jun 19, 2026 Uri Geiger Director Grant or award +789 $15.63 $12,332
Jun 19, 2026 Frank M. Fischer Director Grant or award +1,467 $15.63 $22,929
Jun 19, 2026 Rakhi Kumar Director Grant or award +989 $15.63 $15,458
Jun 5, 2026 R. Scott Huennekens Director Grant or award +2,890 — —
Jun 5, 2026 Frank M. Fischer Director Grant or award +2,890 — —
Jun 5, 2026 Uri Geiger Director Grant or award +2,890 — —
Jun 5, 2026 Rakhi Kumar Director Grant or award +2,890 — —
Jun 5, 2026 Renee Ryan Director Grant or award +2,890 — —
Jun 5, 2026 Lisa Andrade Director Grant or award +2,890 — —
Jun 3, 2026 Joel Becker Director, Officer (CHIEF EXECUTIVE OFFICER) Shares withheld for tax −1,255 $15.88 $19,929
May 27, 2026 Joel Becker Director, Officer (CHIEF EXECUTIVE OFFICER) Shares withheld for tax −1,126 $17.06 $19,210
May 27, 2026 Morrell Martha Officer (CHIEF MEDICAL OFFICER) Shares withheld for tax −358 $17.06 $6,107
May 15, 2026 Patrick F. Williams Officer (Chief Financial Officer) Grant or award +16,820 — —
May 15, 2026 Morrell Martha Officer (CHIEF MEDICAL OFFICER) Grant or award +5,460 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.